Description
*Read carefully the package insert before use.
Performance Data
Within-run reproducibility
(µg/mL)
Sample 1 | Sample 2 | |
---|---|---|
1 | 3.5 | 9.5 |
2 | 3.6 | 9.5 |
3 | 3.5 | 9.4 |
4 | 3.4 | 9.3 |
5 | 3.5 | 9.5 |
6 | 3.5 | 9.3 |
7 | 3.5 | 9.4 |
8 | 3.6 | 9.5 |
9 | 3.5 | 9.3 |
10 | 3.5 | 9.4 |
Mean | 3.5 | 9.4 |
S.D. | 0.06 | 0.09 |
C.V. (%) | 1.6 | 1.0 |
Max. | 3.6 | 9.5 |
Min. | 3.4 | 9.3 |
Range | 0.2 | 0.2 |
On-Board Stability (After Reconstitution)
[on Coapresta 2000]
![On-Board Stability (After Reconstitution)](https://www.sekisuimedical.jp/english/business/diagnostics/blood/p_fdp/img/data_im01.png)
Interference
Concentration | Measured Value(µg/mL) | ||
---|---|---|---|
Base Plasma | Including Interfering Substance | ||
Unconjugated Bilirubin | 20mg/dL | 2.70 | 2.80 |
Conjugated Bilirubin | 20mg/dL | 2.80 | 2.80 |
Hemoglobin | 500mg/dL | 2.12 | 2.14 |
Chyle | 2500 FTU | 2.17 | 2.04 |
Linearity
![Linearity](https://www.sekisuimedical.jp/english/business/diagnostics/blood/p_fdp/img/data_im02.png)
Correlation
![](https://www.sekisuimedical.jp/english/business/diagnostics/blood/p_fdp/img/data_im03.png)
![](https://www.sekisuimedical.jp/english/business/diagnostics/blood/p_fdp/img/data_im04.png)
Assay Procedure on Corepresta 2000
![Assay Procedure on Corepresta 2000](https://www.sekisuimedical.jp/english/business/diagnostics/blood/p_fdp/img/data_im05.png)
Nanopia P-FDP